Ribavirin for chronic hepatitis E virus infection in transplant recipients. - sprookjes - yvandenbroek - TriplyDB

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

http://www.wikidata.org/entity/Q34410881

about

Liver Failure due to Acute Viral Hepatitis (A-E)Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis Hepatitis E Virus Mutations: Functional and Clinical Relevance Hepatitis E virus as an emerging zoonotic pathogen The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges Hepatitis E virus: An ancient hidden enemy in Latin America Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management Hepatitis E virus infection: Epidemiology and treatment implications Chronic hepatitis E: A brief review Hepatitis E in Germany--an under-reported infectious disease Infections after orthotopic liver transplantation Acute Hepatitis E: Two Sides of the Same Coin Therapeutic targets for the treatment of hepatitis E virus infection Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.Hepatitis E: the current state of play.Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.Rabbit Hepatitis E Virus Infections in Humans, France.Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection Management of viral hepatitis in liver transplant recipients Fatal outcome of autochthonous hepatitis E in a patient with B cell lymphoma in Southeastern France Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States.Extended Microbiological Characterization of Göttingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus.Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.Hepatitis E virus is the leading cause of acute viral hepatitis in Lothian, Scotland.Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.Hepatitis E Virus Infection Among Solid Organ Transplant Recipients at a North American Transplant Center.Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins.Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.The relationship between serology of hepatitis E virus with liver and kidney function in kidney transplant patients.Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history?A rat model for hepatitis E virus.Chronic Hepatitis E Infection in a Persistently Immunosuppressed Patient Unable to Be Eliminated after Ribavirin Therapy Hepatitis E in developed countries: current status and future perspectives.Xenotransplantation and Hepatitis E virus.Management in acute liver failure.Treatment of hepatitis C-related kidney disease.Is hepatitis E virus an emerging problem in industrialized countries?

P2860

Q26740326-6FD47E62-094F-48D8-AABA-213B07AF01E6 Q26740390-62612387-0FDD-4642-8520-873A2633E21B Q26741356-A886E79F-507C-487B-A10C-7A6CB4077FB7 Q26751267-06DA5B53-4609-4356-BB53-E028DC684E24 Q26752620-0BCCC6B6-BA99-4F2A-B0F5-29DDEB9D0756 Q26768538-D5006226-A464-49A7-894A-C070178AD02C Q26775005-A68D164F-9941-44D4-B8D0-DD8CFC32C7A1 Q26777044-AA02AAA3-E07B-49DE-980C-542B2ADA55B9 Q26784271-B90F24D7-B295-444B-87C6-339C042BC908 Q27002938-4ADF9925-ADFB-4BA7-A86F-519209CD0246 Q27023182-A6A5248A-617B-4A87-B8AB-7C60A3E7B4FE Q28069291-FDED12E4-3D30-4FC3-AD7B-030BC4342A67 Q28084036-A91847BA-C7CB-4424-A66E-09B5F0873679 Q30234629-117DB8E3-E974-447A-9BDB-002ACC16A363 Q30234939-002DD5BC-8A15-4973-9266-9564A37D8D38 Q30251421-9EC150D7-5C95-4987-9061-2C6BC8F60272 Q33420649-5F21E63E-93D3-4403-8512-6106F6DDD501 Q33908103-11D038D4-032D-43A8-AEED-5360C028C7E0 Q33961593-65C5BB13-C790-46DF-BB58-A126ADB84BB2 Q34779730-9C837ED1-1504-4BEA-8C87-1B34FD25F4A9 Q34916961-574E7451-97D0-428D-8D43-C97E0DE29523 Q35597008-A6000570-130C-4C28-8B9D-15273C5DAC9D Q35806627-A850B3BC-DAFB-4787-B027-B18BCA962A3D Q35853760-8975A6D5-9EC9-4DBE-BE2A-8B193A6D11A5 Q36501929-76FAEEC9-6FC0-4037-957E-8F5E088D1A23 Q36644831-22423279-6802-4431-B913-CAAFB64D472E Q36719709-030F01B8-6A71-4830-A9D0-8BEB79E6838C Q36730005-6B4CA883-3DAC-4931-9A61-388BC8CAD711 Q36835433-95F3F14A-D4FC-4DBE-8D34-922DECD8701E Q36878963-BF07F30E-0B04-4C6F-9997-FB287412EB10 Q36887749-B9F00560-1150-4474-98ED-E6B6A4F970EE Q37054162-D5E59C0F-E163-457E-BE5E-88F8D69C2E67 Q37098206-2AC4A3E2-2BA2-4C85-AC0F-C1F754067AA7 Q37381619-675892F4-C7B2-4F6E-9305-A3762307E9A0 Q37383167-56C215A4-C3E8-4EA4-8360-AAC51BFCCF96 Q38291885-8E8A6AAB-2EB4-4409-88F7-08F4AC869EB9 Q38353549-9BA4325C-F45C-4309-967C-FE78DD33F78B Q38515260-E08541AE-46F3-4A22-A378-283A86C1DCDC Q38544801-5711AB3C-E2F8-4B71-8D3C-812400BA2733 Q38547282-9C714788-D914-41A8-A234-603644816FEC

P2860

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

http://www.wikidata.org/entity/Q34410881

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@ast

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@en

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@nl

type

label

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@ast

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@en

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@nl

prefLabel

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@ast

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@en

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@nl

P1433

Q34410881-F792BE9B-FD27-452B-B967-B08378CBFD6C

P1476

Q34410881-4EFE38B0-A108-4C24-B862-BE59F25FBA1E

P2093

Q34410881-1857D1BB-F91A-4FB5-BDB2-E0B283A8283C

Q34410881-3333CC54-1E4B-48D1-9B8D-A808BA5E7684

Q34410881-36B5EA44-62D5-4B5C-A14E-FE8002947259

Q34410881-40377396-88C6-4859-BD93-25A56A5A66E6

Q34410881-419B9C65-18D8-408C-873B-70D72FB50256

Q34410881-619FE64A-132C-4E89-B543-A10E7FC81F33

Q34410881-6EF05FC4-31E9-40D2-A890-EDD002E3BEDB

Q34410881-8B3B6044-2CD8-4829-B0E0-61E0686C66DA

Q34410881-8C8310E5-A1D2-4020-8D56-FE36D59242DD

Q34410881-8F853389-863D-4E55-9533-D9CABC90B225

P304

Q34410881-9ECFF186-3D1C-409A-9F63-FA9D4BD1B6F0

P31

Q34410881-DDCF1F83-A908-4F2F-998B-A2089423D27E

P356

Q34410881-E4FB8C66-91A2-4652-B7D5-B9B053012AE1

P407

Q34410881-AB3D03B0-C0D1-45D9-9C75-4E018618560A

P433

Q34410881-333034CC-8DE3-4DF5-8F4D-0782E37262B8

P478

Q34410881-923E94FB-937E-47A1-B0E1-FD55FF35B597

P50

Q34410881-109F4F34-A91C-4E78-B148-9BD2FA0E218E

Q34410881-88DA6B03-45DD-4FD6-ABC2-A29128176BCF

Q34410881-95C07597-D05B-49BB-AA03-161745774D65

Q34410881-B14FEC57-BD6F-4B11-AD0E-DC9FDA30EF2F

Q34410881-E79C8984-4624-416D-89FC-B0E70FD0CFA1

Q34410881-F606EA09-57D4-485B-B66C-D8EC7D68072B

P577

Q34410881-705FA1F6-1C08-4171-84D9-9A35D77BF129

P698

Q34410881-EBDCE080-62B9-4AAA-AB3B-903E69B62442

P356

P1433

The New England Journal of Medicine

P1476

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

@en

P2093

Anne Minello

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Roque-Afonso

http://www.w3.org/2001/XMLSchema#string

Audrey Coilly

http://www.w3.org/2001/XMLSchema#string

Jérôme Dumortier

http://www.w3.org/2001/XMLSchema#string

Lionel Couzi

http://www.w3.org/2001/XMLSchema#string

Louis D'Alteroche

http://www.w3.org/2001/XMLSchema#string

Maryvonne Hourmant

http://www.w3.org/2001/XMLSchema#string

Matthias Buchler

http://www.w3.org/2001/XMLSchema#string

Michael Bismuth

http://www.w3.org/2001/XMLSchema#string

Pascal Lebray

http://www.w3.org/2001/XMLSchema#string

P304

1111-1120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1215246

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P50

Jérôme Dumortier

Florence Legrand Abravanel

Lionel Rostaing

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24645943

http://www.w3.org/2001/XMLSchema#string